Thus, these findings shed further insights to the contribution of SOD2 in the maintenance of vascular redox balance and revealed several potential therapeutic targets downstream of SOD2 that may be explored as therapeutic targets in the mitigation of AAA progression and rupture. This evidence concerns the gene SOD2 and triple-A syndrome.